Clinical Report: Evaluating Inflammatory Arthritis Activity through Optical Spectral Transmission

Overview

This systematic review evaluates the diagnostic performance of optical spectral transmission (OST) in assessing inflammatory arthritis activity. It highlights the potential of OST as a rapid, non-invasive tool that may complement traditional assessment methods like ultrasound and MRI.

Background

Inflammatory arthritis encompasses various rheumatic diseases that can lead to significant joint damage and disability if not managed effectively. Current assessment methods, including the Disease Activity Score in 28 joints (DAS28), have limitations, particularly in their subjectivity and applicability across different types of inflammatory arthritis. There is a pressing need for innovative diagnostic tools that provide objective and efficient evaluations of disease activity.

Data Highlights

No numerical data or trial data were provided in the source material.

Key Findings

• OST is a non-invasive imaging technique that measures light absorption in inflamed joints.
• The HandScan device utilizes red and near-infrared laser light wavelengths to assess joint inflammation.
• OST can be performed quickly (approximately 1.5 minutes) and simultaneously on both hands and wrists.
• Operator-independent analysis of OST data enhances reliability and reduces subjectivity in results.
• Factors such as sex, hand size, and presence of osteoarthritis can influence OST's diagnostic accuracy.

Clinical Implications

The introduction of OST may provide healthcare professionals with a valuable tool for the rapid assessment of inflammatory arthritis, potentially improving patient monitoring and treatment outcomes. Its non-invasive nature and ease of use could facilitate more frequent evaluations, aligning with treat-to-target strategies in rheumatology.

Conclusion

Optical spectral transmission represents a promising advancement in the assessment of inflammatory arthritis, addressing some limitations of traditional methods. Further research is needed to fully establish its diagnostic performance and integration into clinical practice.

References

1. European Radiology, 2025 -- Key Insights on Juvenile Idiopathic Arthritis for Radiologists: Recommendations from the European Society of Paediatric Radiology
2. European Radiology, 2022 -- Assessing the Necessity of Contrast in MRI for Evaluating Disease Activity in Knee Juvenile Idiopathic Arthritis Using an Enhanced Protocol with PD-weighted Sequences
3. European Radiology, 2025 -- Distinct Patterns of Structural Damage Identified by MRI in Early Rheumatoid Arthritis: Findings from an 8-Year Longitudinal Study
4. Clinical Rheumatology, 2020 -- Fatigue Shows No Cross-Sectional Link to Objective Inflammation Measures, Yet Variations in Fatigue Correlate with Changes in Disease Activity During Biologic Therapy in Established Rheumatoid Arthritis Patients
5. EULAR, 2025 -- Recommendations Management
6. Clinical utility of ultrasound and MRI in rheumatoid arthritis: An expert review - PubMed
7. Optical spectral transmission to monitor disease activity in arthritis patients: longitudinal follow-up comparison with clinical parameters - PubMed
8. Recommendations Management | EULAR
9. Clinical utility of ultrasound and MRI in rheumatoid arthritis: An expert review - PubMed
10. Optical spectral transmission to monitor disease activity in arthritis patients: longitudinal follow-up comparison with clinical parameters - PubMed